Shivalik Rasayan has informed that the Company has successfully accomplished a major milestone by submitting its first US Drug Master File (DMF) in eCTD format for BORTEZOMIB through ESG gateway to USFDA today.
The above information is a part of company’s filings submitted to BSE.